Fetuin A is assessing of developing bone mineral disorders and cardiovascular calcifi cation formation risk marker in patients with stage 5 chronic kidney disease
Open Access
- 24 November 2022
- journal article
- Published by Non-profit organization Nephrology in Nephrology (Saint-Petersburg)
- Vol. 26 (4) , 105-109
Abstract
Фетуин А – маркер оценки риска развития минерально-костных нарушений и формирования сердечно-сосудистой кальцификации у больных хронической болезнью почек 5Д стадииKeywords
This publication has 8 references indexed in Scilit:
- Preventing CKD in Developed CountriesKidney International Reports, 2020
- Clinical Interventions and All-Cause Mortality of Patients with Chronic Kidney Disease: An Umbrella Systematic Review of Meta-AnalysesJournal of Clinical Medicine, 2020
- Cardiovascular disease in patients with chronic kidney diseaseHerz, 2020
- Renal replacement therapy for End Stage Renal Disease in Russian Federation, 2014-2018. Russian National Renal Replacement Therapy Registry Report of Russian Public Organization of Nephrologists “Russian Dialysis Society”2020
- Circulating Fetuin-A and Risk of All-Cause Mortality in Patients With Chronic Kidney Disease: A Systematic Review and Meta-AnalysisFrontiers in Physiology, 2019
- Clinical implications of fetuin-A2019
- Fetuin-A and Albumin Alter Cytotoxic Effects of Calcium Phosphate Nanoparticles on Human Vascular Smooth Muscle CellsPLOS ONE, 2014
- Anti-Inflammatory Role of Fetuin-A in Injury and InfectionCurrent Molecular Medicine, 2012